- Home
- RSLS vs NCPL Comparison
RSLS vs NCPL Comparison
Compare RSLS & NCPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSLS
- NCPL
- Stock Information
- Founded
- RSLS 2002
- NCPL 1984
- Country
- RSLS United States
- NCPL United States
- Employees
- RSLS N/A
- NCPL N/A
- Industry
- RSLS Medical/Dental Instruments
- NCPL Investment Managers
- Sector
- RSLS Health Care
- NCPL Finance
- Exchange
- RSLS Nasdaq
- NCPL Nasdaq
- Market Cap
- RSLS 4.5M
- NCPL 4.3M
- IPO Year
- RSLS 2007
- NCPL N/A
- Fundamental
- Price
- RSLS $6.66
- NCPL $1.92
- Analyst Decision
- RSLS Hold
- NCPL
- Analyst Count
- RSLS 1
- NCPL 0
- Target Price
- RSLS N/A
- NCPL N/A
- AVG Volume (30 Days)
- RSLS 17.0M
- NCPL 42.6K
- Earning Date
- RSLS 05-19-2025
- NCPL 03-17-2025
- Dividend Yield
- RSLS N/A
- NCPL N/A
- EPS Growth
- RSLS N/A
- NCPL N/A
- EPS
- RSLS N/A
- NCPL N/A
- Revenue
- RSLS $8,006,000.00
- NCPL $812,612.00
- Revenue This Year
- RSLS $52.80
- NCPL N/A
- Revenue Next Year
- RSLS N/A
- NCPL $101.16
- P/E Ratio
- RSLS N/A
- NCPL N/A
- Revenue Growth
- RSLS N/A
- NCPL N/A
- 52 Week Low
- RSLS $0.30
- NCPL $1.41
- 52 Week High
- RSLS $29.00
- NCPL $22.82
- Technical
- Relative Strength Index (RSI)
- RSLS 38.68
- NCPL 50.02
- Support Level
- RSLS $9.75
- NCPL $1.75
- Resistance Level
- RSLS $11.65
- NCPL $2.15
- Average True Range (ATR)
- RSLS 1.23
- NCPL 0.10
- MACD
- RSLS 0.52
- NCPL -0.01
- Stochastic Oscillator
- RSLS 13.19
- NCPL 42.50
About RSLS ReShape Lifesciences Inc.
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus. Geographically, the company operates in the United States, Australia, Europe, and the Rest of world, and the majority of its revenue is generated from the United States.
About NCPL Netcapital Inc.
Netcapital Inc is a financial technology company. The company facilitates the growth of private companies by providing fundraising services and other consulting services. The company's online private investment platform connects entrepreneurs and investors, enabling companies to raise capital digitally. The Company operates in a single operating segment, which is the provision of fintech services.